We are pleased to offer the Revage Laser System for both male and female patients! Using Rotational PhotoTherapy (RPT), the system contains 30 laser diodes that rotate 180 degrees around the scalp. By increasing the contact of the laser energy with the hair follicles Laser Hair Therapy will make your hair look healthier and fuller reducing the appearance of thinning hair.
Revåge belongs to a class of lasers that has been clinically and scientifically proven to safely and effectively stimulate cellular metabolism, protein synthesis and regenerate tissue while increasing blood perfusion rates. An increase in blood perfusion rates has been linked to a healthy scalp and hair follicle. Visible results with the Revåge Cool Laser Therapy occur within weeks.
According to Researchers, the Revåge has shown to increase hair counts in men by an average of 37.78% within 16 weeks of treatment with no incidence of side effects.
The Revage Laser is safe, fast, and painless, and is suitable for all hair types and skin colors. Call 925-939-4763 us today!
For years, Dr. Sara has researched lasers which purport to grow hair or speed wound healing – and due to her interest in lasers in general she has actively investigated whether these devices will be able to help her patients who have no other medical or surgical options.
THE RESULT OF INVESTIGATIONAL STUDIES CONDUCTED BY INDEPENDENT RESEARCHERS SHOWS THE Revåge 670 TMOFFERS DOCUMENTED BENEFITS FOR SHEDDING AND THINNING HAIR.*
The phenomenon of Light. Aggregate data in over a decade of scientific studies of cool laser treatments has yielded impressive data. In European studies, significant increases in hair density and a remarkable 85% success in halting the progression of shedding has been noted. It’s the dynamic, rotational tuning in the Revage 670TM Cool Laser that optimizes results.
Revage 670TM belongs to a class of lasers that has been clinically and scientifically proven to safely and effectively stimulate cellular metabolism, protein synthesis and regenerate tissue while increasing blood perfusion rates. An increase in blood perfusion rates has been linked to a healthy scalp and hair follicle. Visible results with the Revåge 670TM Cool Laser Therapy occur within weeks.
For those patients who have recently had hair restoration surgery, Dr. Wasserbauer is now offering free treatment with the Revage 670 laser as seen on The Doctors. This is a low-level laser treatment for thinning hair that has been approved for safety by the FDA. Patients who might also benefit from laser hair treatment include:
- Female patients
- Patients with thin hair but not complete loss
- Patients with diffuse hair loss
- Patients who cannot take drugs or are not candidates for surgery
Treatments are 20-30 minutes twice per week for the first 6 weeks and the once per week thereafter. Typically, patients find the best results with ongoing therapy or periodic maintenance visits, but since the sessions can be self-administered (you sign yourself in each time) the regimen is very flexible.
Hair Life Cycles and Revåge 670TM utilizing Rotational Phototherapy
Hair has a life cycle in which growth only takes place during the anagen phase. According to research, Low Level Light Therapy similar to the Revåge 670TM was responsible for inducing dormant hair follicles into the Anagen Phase. The stimulation generates a more vital, robust hair than follicles can generate on their own
The Picture of Possibilities
Only Revåge 670TM therapy incorporates an integral microscope/camera system that clearly shows each new patient the number of dormant hair follicles in a square centimeter that can be put into the anagen phase of growth. This system dramatically demonstrates improvement throughout therapy.
* The REVAGE 670 has not been cleared by the FDA for medical use and any references are purely investigational.
** G M Charles, DO “A Retrospective Study to Investigate and Evaluate the Unanticipated Results of Hair Loss Cessation and Temporary Hair Regrowth in Adult Males Who Had Undergone Low Level Laser Therapy for Hair Wellness” Medical Insight March/April 2006